Literature DB >> 8238387

Effect of prostaglandin synthesis inhibition on macula densa-stimulated renin secretion.

S G Greenberg1, J N Lorenz, X R He, J B Schnermann, J P Briggs.   

Abstract

The purpose of the present studies was to evaluate directly the role of prostaglandins in macula densa-mediated renin release. Individual juxtaglomerular apparatus specimens were microdissected from rabbit kidney and perfused with a solution containing either high NaCl (Na+ = 141 meq/l; Cl- = 122 meq/l) or low NaCl (Na+ = 26 meq/l; Cl- = 7 meq/l) concentration. With a step decrease in perfusate NaCl (high to low), renin secretion rate was markedly stimulated (from 15.06 to 63.1 nGU/min, P < 0.01), and the response was almost fully reversible. When specimens were bathed with cyclooxygenase inhibitors flurbiprofen (10(-5) M) or flufenamic acid (10(-4) M), this macula densa-activated increase in renin release was largely or completely abolished (flurbiprofen, 3.5-10.5 nGU/min, not significant; flufenamic acid, 9.0-12.3 nGU/min, not significant). Exposing the macula densa to a step increase in perfusate NaCl concentration (low to high) resulted in a significant and reversible suppression of renin secretion in control specimens, but no significant suppression was seen in specimens treated with flufenamic acid. These data provide direct evidence to support the hypothesis that locally produced prostaglandins may act as a primary mediator of the renin response to macula densa activation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8238387     DOI: 10.1152/ajprenal.1993.265.4.F578

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  12 in total

Review 1.  Tubular control of renin synthesis and secretion.

Authors:  Jurgen Schnermann; Josephine P Briggs
Journal:  Pflugers Arch       Date:  2012-06-05       Impact factor: 3.657

Review 2.  Convergence of major physiological stimuli for renin release on the Gs-alpha/cyclic adenosine monophosphate signaling pathway.

Authors:  Soo Mi Kim; Josephine P Briggs; Jurgen Schnermann
Journal:  Clin Exp Nephrol       Date:  2011-11-01       Impact factor: 2.801

3.  A major role for the EP4 receptor in regulation of renin.

Authors:  Carie S Facemire; Mytrang Nguyen; Leigh Jania; William H Beierwaltes; Hyung-Suk Kim; Beverly H Koller; Thomas M Coffman
Journal:  Am J Physiol Renal Physiol       Date:  2011-08-10

Review 4.  Physiology and Pathophysiology of the Intrarenal Renin-Angiotensin System: An Update.

Authors:  Tianxin Yang; Chuanming Xu
Journal:  J Am Soc Nephrol       Date:  2017-03-02       Impact factor: 10.121

5.  Inhibition of cyclooxygenase-2 in hematopoietic cells results in salt-sensitive hypertension.

Authors:  Ming-Zhi Zhang; Bing Yao; Yinqiu Wang; Shilin Yang; Suwan Wang; Xiaofeng Fan; Raymond C Harris
Journal:  J Clin Invest       Date:  2015-10-20       Impact factor: 14.808

6.  Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction.

Authors:  R C Harris; J A McKanna; Y Akai; H R Jacobson; R N Dubois; M D Breyer
Journal:  J Clin Invest       Date:  1994-12       Impact factor: 14.808

7.  Angiotensin II attenuates renal cortical cyclooxygenase-2 expression.

Authors:  H F Cheng; J L Wang; M Z Zhang; Y Miyazaki; I Ichikawa; J A McKanna; R C Harris
Journal:  J Clin Invest       Date:  1999-04       Impact factor: 14.808

8.  Role of p38 in the regulation of renal cortical cyclooxygenase-2 expression by extracellular chloride.

Authors:  H F Cheng; J L Wang; M Z Zhang; J A McKanna; R C Harris
Journal:  J Clin Invest       Date:  2000-09       Impact factor: 14.808

Review 9.  Salt feedback on the renin-angiotensin-aldosterone system.

Authors:  Frank Schweda
Journal:  Pflugers Arch       Date:  2014-12-13       Impact factor: 3.657

10.  Macrophage Cyclooxygenase-2 Protects Against Development of Diabetic Nephropathy.

Authors:  Xin Wang; Bing Yao; Yinqiu Wang; Xiaofeng Fan; Suwan Wang; Aolei Niu; Haichun Yang; Agnes Fogo; Ming-Zhi Zhang; Raymond C Harris
Journal:  Diabetes       Date:  2016-11-04       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.